Approximately 1.9 million stillbirths – babies born with no sign of life at 28 weeks of pregnancy or later – occurred worldwide in 2021. According to the latest data, 1 in 72 total births globally resulted in a stillborn baby, or one every 17 seconds [1]. Additionally, an estimated 240,000 newborns worldwide die within 28 days of birth every year due to congenital disorders [2], while annually, 3%-6% of infants globally are born with a serious birth defect [3]. Birth defects are a leading cause of death for infants and young children globally, and those who survive and live with these conditions are at increased risk for lifelong disabilities. The critical goal is to detect – as early as possible – any chromosomal, congenital or growth abnormalities that can lead to long-term health issues or other adverse outcomes. In gynecological care, early detection and diagnostic confidence are essential to a woman’s wellbeing.

“Philips is a leader in providing innovative OB/GYN advanced visualization tools specifically designed to aid in efficient routine screening and care and to assist clinicians in detecting abnormalities early,” said Matthijs Groot Wassink, General Manager of Access and OB Ultrasound at Philips. “We’ve built intelligently guided workflows and ways for clinicians to efficiently collaborate across specialties for more confident diagnoses at more points of care, supporting women with the peace of mind they deserve during every stage of their health journey. Our full range of AI-enabled ultrasound imaging solutions allows doctors to deliver excellence in care – from clinics and hospitals to emergency and rural or remote settings worldwide.”